[HTML] Characterizing apolipoprotein E ε4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal β-amyloid peptide …
SE Monsell, WA Kukull, AE Roher, CL Maarouf… - JAMA …, 2015 - jamanetwork.com
Importance β-Amyloid peptide (Aβ) plaques are a cardinal neuropathologic feature of
Alzheimer disease (AD), yet more than one-third of apolipoprotein E ε4 (APOE4) noncarriers
with the clinical diagnosis of mild to moderate Alzheimer dementia may not meet positron
Alzheimer disease (AD), yet more than one-third of apolipoprotein E ε4 (APOE4) noncarriers
with the clinical diagnosis of mild to moderate Alzheimer dementia may not meet positron
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论